Psychiatr. praxi. 2013;14(1):30-33
Agitation is a very frequent behavioral manifestation of dementia. Antipsychotic drugs are used in pharmacotherapy; they are, however,
associated with a significant risk of adverse effects. Theoretical assumptions as well as clinical experience show a good effect of
selective serotonin reuptake inhibitors in this indication. At the gerontopsychiatric ward of a mental hospital, we studied the efficacy
and tolerability of escitalopram drops (Cipralex 20 mg/ml oral drops, solution) in 38 patients with dementia hospitalized for agitation as
well as other behavioral disorders. We were surprised by a rapid onset of action (from day 3 of use), excellent tolerability, and effect of
the medication (significant improvement in 28 patients).
Published: December 1, 2012 Show citation
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...